These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14653828)

  • 21. Dilated intercellular spaces as a marker of oesophageal damage: comparative results in gastro-oesophageal reflux disease with or without bile reflux.
    Calabrese C; Fabbri A; Bortolotti M; Cenacchi G; Areni A; Scialpi C; Miglioli M; Di Febo G
    Aliment Pharmacol Ther; 2003 Sep; 18(5):525-32. PubMed ID: 12950425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors.
    Katz PO; Anderson C; Khoury R; Castell DO
    Aliment Pharmacol Ther; 1998 Dec; 12(12):1231-4. PubMed ID: 9882031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reflux rising! An essay on witnessing a disease in evolution.
    Bardhan KD; Royston C; Nayyar AK
    Dig Liver Dis; 2006 Mar; 38(3):163-8. PubMed ID: 16297671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity.
    Nehra D; Howell P; Williams CP; Pye JK; Beynon J
    Gut; 1999 May; 44(5):598-602. PubMed ID: 10205192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoscopic appearance of GERD: putative role of cell proliferation.
    Calabrese C; Trerè D; Fabbri A; Cenacchi G; Vici M; Derenzini M; Di Febo G
    Dig Liver Dis; 2007 Aug; 39(8):713-9. PubMed ID: 17606421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review: does gastro-oesophageal reflux disease progress?
    Fullard M; Kang JY; Neild P; Poullis A; Maxwell JD
    Aliment Pharmacol Ther; 2006 Jul; 24(1):33-45. PubMed ID: 16803601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review article: the role of acid suppression in patients with non-erosive reflux disease or functional heartburn.
    DeVault KR
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():33-9. PubMed ID: 16483268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lansoprazole heals erosive reflux oesophagitis in patients with Barrett's oesophagus.
    Sontag SJ; Schnell TG; Chejfec G; Kurucar C; Karpf J; Levine G
    Aliment Pharmacol Ther; 1997 Feb; 11(1):147-56. PubMed ID: 9042987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the main oesophageal pathophysiological characteristics between short- and long-segment Barrett's oesophagus.
    Zentilin P; Conio M; Mele MR; Mansi C; Pandolfo N; Dulbecco P; Gambaro C; Tessieri L; Iiritano E; Bilardi C; Biagini R; Vigneri S; Savarino V
    Aliment Pharmacol Ther; 2002 May; 16(5):893-8. PubMed ID: 11966497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The extent of duodenogastric reflux in gastro-oesophageal reflux disease.
    Marshall RE; Anggiansah A; Owen WA; Manifold DK; Owen WJ
    Eur J Gastroenterol Hepatol; 2001 Jan; 13(1):5-10. PubMed ID: 11204810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 24 hour ambulatory oesophageal pH monitoring in uncomplicated Barrett's oesophagus.
    Neumann CS; Cooper BT
    Gut; 1994 Oct; 35(10):1352-5. PubMed ID: 7959184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysfunction of oesophageal motility in Helicobacter pylori-infected patients with reflux oesophagitis.
    Wu JC; Lai AC; Wong SK; Chan FK; Leung WK; Sung JJ
    Aliment Pharmacol Ther; 2001 Dec; 15(12):1913-9. PubMed ID: 11736722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oesophageal acid exposure: higher in Barrett's oesophagus than in reflux oesophagitis.
    Salminen JT; Tuominen JA; Rämö OJ; Färkkilä MA; Salo JA
    Ann Med; 1999 Feb; 31(1):46-50. PubMed ID: 10219713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of acid exposure immediately above the gastro-oesophageal squamocolumnar junction: evidence of short segment reflux.
    Fletcher J; Wirz A; Henry E; McColl KE
    Gut; 2004 Feb; 53(2):168-73. PubMed ID: 14724145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daytime gastro-oesophageal reflux is important in oesophagitis.
    de Caestecker JS; Blackwell JN; Pryde A; Heading RC
    Gut; 1987 May; 28(5):519-26. PubMed ID: 3596333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn.
    Frazzoni M; De Micheli E; Zentilin P; Savarino V
    Aliment Pharmacol Ther; 2004 Jul; 20(1):81-8. PubMed ID: 15225174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease.
    Caviglia R; Ribolsi M; Gentile M; Rabitti C; Emerenziani S; Guarino MP; Petitti T; Cicala M
    Aliment Pharmacol Ther; 2007 Mar; 25(5):629-36. PubMed ID: 17305764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis.
    Wu JC; Chan FK; Wong SK; Lee YT; Leung WK; Sung JJ
    Aliment Pharmacol Ther; 2002 Mar; 16(3):545-52. PubMed ID: 11876709
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.